Masashi Hirooka - Concepedia

Author

Masashi Hirooka

Also Known As

F berg, Giada Sebastiani, H Miyata, Hirooka Masashi, Hirooka, M., M HIROOKA, M Hirooka, M. Hirooka, M. Hirooka M.D., M., Hirooka

465

Publications

8.2K

Citations

H-Index

153

Concepts

All Affiliations

Ehime University Ehime Prefectural Central Hospital Matsuyama Red Cross Hospital Ogaki Municipal Hospital Teine Keijinkai Hospital

About

Masashi Hirooka is an author at Ehime University specializing in medicine, hepatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	52	1.9K
2	Health Sciences	18	31	1K
3	Public Health	3	3	133
4	Engineering	2	2	54
5	Allergy	1	1	21

Masashi Hirooka

188

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis Atsushi Hiraoka, Takashi Kumada, Kunihiko Tsuji, Liver Cancer	2018	230
Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications Atsushi Hiraoka, Takashi Kumada, Masatoshi Kudo, Liver Cancer	2017	208
A Technique for the Measurement of Visceral Fat by Ultrasonography: Comparison of Measurements by Ultrasonography and Computed Tomography Masashi Hirooka, Teru Kumagi, Kiyotaka Kurose, Internal Medicine	2005	164
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis Atsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, Cancer Medicine	2019	158
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma Tokuzo Arao, Kazuomi Ueshima, Tomoyuki Nagai, Hepatology	2012	152
Liver Fibrosis in Patients with Chronic Hepatitis C: Noninvasive Diagnosis by Means of Real-time Tissue Elastography—Establishment of the Method for Measurement Yohei Koizumi, Masashi Hirooka, Yoshiyasu Kisaka, Radiology	2011	150
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis Atsushi Hiraoka, Takashi Kumada, Masatoshi Kudo, Digestive Diseases Surgical OncologySorafenib TreatmentPathologyHepatic FunctionHcc Patients	2017	144
Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis Atsushi Hiraoka, Kojiro Michitaka, Daisuke Kiguchi, European Journal of Gastroenterology & Hepatology	2017	131
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis Atsushi Hiraoka, Takashi Kumada, Kazuya Kariyama, Cancer Medicine	2018	130
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima, ESMO Open	2022	124

Page 1